The Hindu Business Line : Eli Lilly launches cancer drug

Eli Lilly and Company India today announced the launch of Alimta (pemetrexed disodium) for the treatment of patients with malignant pleural mesothelioma (MPM) — a rare type of cancer that has strong correlation with exposure to asbestos.

Alimta has also been approved as second line treatment for non small-cell lung cancer. Eli Lilly CMD, Mr Sandeep Gupta, in a company release, said, "We are delighted to launch Alimta, the world's first approved treatment for malignant pleural mesothelioma which reinforces our strong commitment to introduce innovative solutions from Lilly for benefit of patients in India." The drug was approved in 2004 in the US. Since then it has been approved in more than 70 countries and regions including the EU, Australia and Canada, the release said.

More Stories on : New Products & Services | Health | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Hyundai to roll out new car from second plant

NDDB to make ice cream with natural vanillin

Zee Network signs deal with China television network

Cartoon Network to keep Pogo toys affordable

Club Mahindra plans more resorts

Western Digital brings service to the doorstep

Seminar on ISO certification

MTR Foods plans sales push thru' direct consumer contact

PGC enters apparel retailing

Adecco, Tata Institute sign pact

Cherry Blossom brand turns 100

Jupiter Capital to invest Rs 100 cr

After clear glass, Saint-Gobain moves up the value chain

Eli Lilly launches cancer drug

APC InfraStruXure available